Thermo Fisher Scientific financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$32.22B $25.54B $24.36B $20.92B $18.27B $16.97B $16.89B $13.09B $12.51B $11.56B $10.39B $9.91B $10.50B $9.75B $3.79B $2.63B $2.21B $39.21B $44.92B $42.86B $0.00M
GM % Gross Margin %
49.69% 44.42% 44.62% 45.59% 46.24% 45.77% 46.17% 42.46% 42.77% 42.10% 41.13% 39.39% 40.08% 39.54% 41.36% 45.89% 46.14% 50.08% 42.30% 41.01% 0.00%
OM Operating Margin
24.44% 16.69% 15.93% 15.40% 15.35% 14.75% 13.53% 13.67% 13.05% 12.82% 12.27% 10.76% 12.06% 10.93% 8.44% 11.16% 11.64% 26.08% 19.12% 17.24% 0.00%
EPS Earnings Per Share
$1.55 $1.82 $2.65 $3.16 $3.05 $3.57 $4.16 $4.94 $5.42 $6.96 $7.39 $8.27 $9.49 $11.12 $12.35 $19.55 $25.13 $23.24 $21.55 $0.00
Div. Dividends
$0.88 $0.76 $0.68 $0.60 $0.60 $0.60 $0.60 $0.60 $0.54 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.04 $1.20 $1.36 $0.00
PR % Payout Ratio %
4.50% 6.15% 6.12% 6.32% 7.26% 8.12% 8.62% 11.07% 10.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.14% 5.16% 6.31% 0
Sha. Shares
396.34m 400.99m 402.58m 401m 395.03m 399.1m 400.03m 361.37m 360.21m 378.28m 397.48m 408.31m 420.21m 420.06m 409.18m 162.25m 159.95m 393.02m 391.44m 386.37m 386.37m
OCF Operating Cash Flow
$8.29B $4.97B $4.54B $4.01B $3.26B $2.94B $2.62B $2.01B $2.04B $1.69B $1.50B $1.66B $1.42B $1.48B $405.70M $270.90M $264.51M $9.31B $9.15B $8.41B $0.00M
FCF Free Cash Flow
$6.82B $4.05B $3.79B $3.50B $2.74B $2.39B $2.19B $1.75B $1.72B $1.42B $1.24B $1.46B $1.16B $1.31B $328.90M $227.30M $214.52M $7.02B $6.94B $6.65B $0.00M
FCFS Free Cash Flow Per Share
$17.21 $10.12 $9.42 $8.85 $7.12 $6.31 $5.50 $4.80 $4.74 $3.76 $3.11 $3.54 $2.76 $3.10 $1.68 $1.41 $1.32 $17.23 $17.63 $17.95 $0.00